{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T19:47:25Z","timestamp":1776282445499,"version":"3.50.1"},"reference-count":26,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Cir. Bras."],"abstract":"<jats:p>ABSTRACT  Purpose: To establish an acetic acid-induced acute ulcerative colitis model in rats and to evaluate the clinical, biochemical, and histopathological effects of thymoquinone (TQ) and caffeic acid phenethyl ester (CAPE) in this model.  Methods: Forty male Wistar albino rats (190\u2013303 g) were randomly assigned to five groups (n = 8). All groups except the control received rectal acetic acid (4%) to induce colitis. Group 1 (control) received intraperitoneally (IP) 0.9% saline for five days. Group 2 (colitis) received IP 10% ethanol (vehicle for CAPE). Group 3 (TQ) received IP thymoquinone (10 mg\/kg\/day). Group 4 (CAPE) received IP caffeic acid phenethyl ester (10 \u00b5mol\/kg\/day). Group 5 (TQ+CAPE) received both agents at the same doses. On day 5, animals were euthanized, and colon and serum samples were collected for biochemical and histopathological analysis.  Results: Significant differences were observed in the disease activity index, tumor necrosis factor-\u03b1, catalase, glutathione peroxidase, interleukin-10, and malondialdehyte indicating a balance between oxidant and antioxidant parameters. CAPE was found to have a greater anti-inflammatory effect than TQ histopathologically. The combined administration of CAPE and TQ mitigated oxidative stress as demonstrated by decreased oxidative stress biomarkers and improved antioxidant protection.  Conclusion: Both CAPE and TQ demonstrated anti-inflammatory and antioxidant effects in an acetic acid-induced colitis model, with CAPE showing greater histological improvement. Their combined administration yielded additional benefits in oxidative stress reduction. These findings suggest that CAPE and TQ, particularly in combination, may hold promise as adjunctive agents in colitis management and warrant further investigation.<\/jats:p>","DOI":"10.1590\/acb412226","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T18:19:27Z","timestamp":1776277167000},"source":"Crossref","is-referenced-by-count":0,"title":["Thymoquinone and caffeic acid phenethyl ester mitigate experimental ulcerative colitis: a biochemical and histopathological study"],"prefix":"10.1590","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9658-6063","authenticated-orcid":false,"given":"Can","family":"Ersak","sequence":"first","affiliation":[{"name":"Health Sciences University,  Turkey; Kizilcahamam State Hospital,  Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5289-3718","authenticated-orcid":false,"given":"Ender","family":"Erg\u00fcder","sequence":"additional","affiliation":[{"name":"Health Sciences University,  Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2468-2996","authenticated-orcid":false,"given":"Jafar Nouri","family":"Nojadeh","sequence":"additional","affiliation":[{"name":"Ankara University,  Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6118-9984","authenticated-orcid":false,"given":"Saygin","family":"Altiner","sequence":"additional","affiliation":[{"name":"Gazi University,  Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5566-8134","authenticated-orcid":false,"given":"Mevlut Recep","family":"Pekcici","sequence":"additional","affiliation":[{"name":"Health Sciences University,  Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2026]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"42995","DOI":"10.1038\/srep42995","article-title":"Thymoquinone: An IRAK1 inhibitor with in vivo and in vitro anti-inflammatory activities","volume":"7","author":"Hossen MJ","year":"2017","journal-title":"Sci Rep"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.taap.2015.06.017","article-title":"Thymoquinone inhibits TNF-\u03b1-induced inflammation and cell adhesion in rheumatoid arthritis synovial fibroblasts by ASK1 regulation","volume":"287","author":"Umar S","year":"2015","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.phrs.2015.03.011","article-title":"Thymoquinone and its therapeutic potentials","volume":"95-96","author":"Darakhshan S","year":"2015","journal-title":"Pharmacol Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"145342","DOI":"10.1155\/2014\/145342","article-title":"Caffeic acid phenethyl ester and therapeutic potentials","volume":"2014","author":"Murtaza G","year":"2014","journal-title":"Biomed Res Int"},{"issue":"7","key":"ref5","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s00210-021-02054-w","article-title":"Recent progresses in the pharmacological activities of caffeic acid phenethyl ester","volume":"394","author":"Lv L","year":"2021","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00535-018-1439-1","article-title":"Evidence-based clinical practice guidelines for inflammatory bowel disease","volume":"53","author":"Matsuoka K","year":"2018","journal-title":"J Gastroenterol"},{"issue":"10080","key":"ref7","first-page":"1756","article-title":"Ulcerative colitis","volume":"389","author":"Ungaro R","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.1038\/s41598-025-89128-4","article-title":"Disulfidptosis links the pathophysiology of ulcerative colitis and immune infiltration in colon adenocarcinoma","volume":"15","author":"Jiang C","year":"2025","journal-title":"Sci Rep"},{"issue":"9","key":"ref9","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1007\/BF01303184","article-title":"Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin","volume":"38","author":"Murthy S","year":"1993","journal-title":"Dig Dis Sci"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/ajg.2009.727","article-title":"Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee","volume":"105","author":"Kornbluth A","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ajg.2010.392","article-title":"The London position statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn\u2019s and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?","volume":"106","author":"D\u2019Haens GR","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1007\/s10875-012-9843-4","article-title":"IL-10- and IL-20-expressing epithelial and inflammatory cells are increased in patients with ulcerative colitis","volume":"33","author":"Fonseca-Camarillo G","year":"2013","journal-title":"J Clin Immunol"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1365-2249.2003.02268.x","article-title":"Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis","volume":"134","author":"Melgar S","year":"2003","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"ref14","first-page":"568","article-title":"Role of oxidative stress and antioxidant defence in ulcerative colitis patients from North India","volume":"139","author":"Rana SV","year":"2014","journal-title":"Indian J Med Res"},{"issue":"2","key":"ref15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000260417","article-title":"The Toll-like receptor 4 D299G and T399I polymorphisms are associated with Crohn\u2019s disease and ulcerative colitis: a meta-analysis","volume":"81","author":"Shen X","year":"2010","journal-title":"Digestion"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.clinbiochem.2004.10.003","article-title":"Effects of caffeic acid phenethyl ester on lipid peroxidation and antioxidant enzymes in diabetic rat heart","volume":"38","author":"Okutan H","year":"2005","journal-title":"Clin Biochem"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.clim.2008.02.009","article-title":"Visilizumab induces apoptosis of mucosal T lymphocytes in ulcerative colitis through activation of caspase 3 and 8 dependent pathways","volume":"127","author":"Yu QT","year":"2008","journal-title":"Clin Immunol"},{"issue":"6","key":"ref18","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1136\/gut.2008.153981","article-title":"Therapeutic potency of IL2\u2013caspase 3 targeted treatment in a murine experimental model of inflammatory bowel disease","volume":"58","author":"Shteingart S","year":"2009","journal-title":"Gut"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/path.1409","article-title":"Intestinal oxidative damage in inflammatory bowel disease: semiquantification, localization, and association with mucosal antioxidants","volume":"201","author":"Kruidenier L","year":"2003","journal-title":"J Pathol"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1046\/j.1365-2036.1996.57199000.x","article-title":"Xanthine oxidase activity is not increased in the colonic mucosa of ulcerative colitis","volume":"10","author":"Reynolds PD","year":"1996","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000199368","article-title":"Detectable colonic nitrite levels in inflammatory bowel disease: mucosal or bacterial malfunction?","volume":"35","author":"Roediger WE","year":"1986","journal-title":"Digestion"},{"issue":"8867","key":"ref22","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/0140-6736(93)91476-3","article-title":"Nitric oxide synthase activity in ulcerative colitis and Crohn\u2019s disease","volume":"342","author":"Boughton-Smith NK","year":"1993","journal-title":"Lancet"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/S0022-3565(25)23789-2","article-title":"Effects of nitric oxide synthase inhibition on the pathophysiology observed in a model of chronic granulomatous colitis","volume":"271","author":"Grisham MB","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1053\/gast.1997.v112.pm9041266","article-title":"Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation","volume":"112","author":"McCafferty DM","year":"1997","journal-title":"Gastroenterology"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0378-4274(03)00173-5","article-title":"Thymoquinone protects against experimental colitis in rats","volume":"143","author":"Mahgoub AA","year":"2003","journal-title":"Toxicol Lett"},{"issue":"11","key":"ref26","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/j.prp.2018.08.020","article-title":"Caffeic acid phenethyl ester (CAPE) reverses fibrosis caused by chronic colon inflammation in murine model of colitis","volume":"214","author":"Tambuwala MM","year":"2018","journal-title":"Pathol Res Pract"}],"container-title":["Acta Cir\u00fargica Brasileira"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0102-86502026000100611&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T18:57:20Z","timestamp":1776279440000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0102-86502026000100611&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":26,"alternative-id":["S0102-86502026000100611"],"URL":"https:\/\/doi.org\/10.1590\/acb412226","relation":{},"ISSN":["1678-2674","0102-8650"],"issn-type":[{"value":"1678-2674","type":"electronic"},{"value":"0102-8650","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"e412226"}}